Pembrolizumab,Lenvatinib,Sunitinib,Everolimus
merck,eisai,pfizer
['keytruda', 'lenvima', 'renal,(-adrenal)']
watch: from explains how four-year data show that lenvima + keytruda "stood the test of time" for the treatment of advanced renal cell carcinoma. #asco23 #kidneycancer 
Cancer updates, research and education for patients with cancer, survivors and their caregivers to become empowered advocates in their journey.